Stock Index Futures Gain on U.S.-China Trade Optimism, Jobs Report in Focus
June S&P 500 E-Mini futures (ESM25) are up +0.44%, and June Nasdaq 100 E-Mini futures (NQM25) are up +0.30% this morning as sentiment got a boost after China said it is assessing the possibility of trade talks with the U.S., with the focus now shifting to the key U.S. payrolls report.
China's Commerce Ministry stated on Friday that it had observed senior U.S. officials repeatedly voicing their readiness to engage with Beijing on tariffs, and called on Washington to demonstrate 'sincerity' toward China. 'The U.S. has recently sent messages to China through relevant parties, hoping to start talks with China. China is currently evaluating this,' the ministry added.
However, disappointing earnings from Apple and Amazon limited gains in stock index futures. Apple (AAPL) fell over -2% in pre-market trading after the iPhone maker reported weaker-than-expected FQ2 sales in China. Also, Amazon.com (AMZN) slid more than -2% in pre-market trading after the world's largest online retailer provided a below-consensus Q2 operating income forecast.
In yesterday's trading session, Wall Street's major indices closed in the green, with the S&P 500 and Dow notching 4-week highs and the Nasdaq 100 posting a 5-week high. Microsoft (MSFT) surged over +7% and was the top percentage gainer on the Dow after the world's largest software maker reported stronger-than-expected FQ3 results and provided an upbeat FQ4 revenue growth forecast for the Azure cloud unit. Also, Meta Platforms (META) climbed more than +4% after the maker of Facebook and Instagram posted upbeat Q1 results. In addition, Nvidia (NVDA) gained over +2% after Bloomberg reported that the U.S. was considering a possible relaxation of restrictions on the chipmaker's sales to the United Arab Emirates. On the bearish side, Becton Dickinson & Co. (BDX) tumbled more than -18% and was the top percentage loser on the S&P 500 after cutting its annual adjusted EPS guidance. Also, Qualcomm (QCOM) slumped over -8% and was the top percentage loser on the Nasdaq 100 after the mobile chip designer provided a tepid FQ3 revenue forecast.
Economic data released on Thursday showed that the U.S. ISM manufacturing index fell to a 5-month low of 48.7 in April, though it came in above expectations of 48.0. Also, U.S. March construction spending unexpectedly fell -0.5% m/m, weaker than expectations of +0.2% m/m and the largest decline in 6 months. In addition, the number of Americans filing for initial jobless claims in the past week rose +18K to a 2-month high of 241K, compared with the 224K expected.
Meanwhile, U.S. rate futures have priced in a 93.2% probability of no rate change and a 6.8% chance of a 25 basis point rate cut at next week's FOMC meeting.
On the earnings front, notable companies like Exxon Mobil (XOM), Chevron (CVX), Cigna (CI), and Apollo Global Management (APO) are slated to release their quarterly results today. According to Bloomberg Intelligence, companies in the S&P 500 are expected to post an average +6.7% increase in quarterly earnings for Q1 compared to the previous year.
Today, all eyes are focused on the U.S. monthly payroll report, which is set to be released in a couple of hours. Economists, on average, forecast that April Nonfarm Payrolls will come in at 138K, compared to the March figure of 228K.
U.S. Average Hourly Earnings data will also be closely watched today. Economists expect April figures to be +0.3% m/m and +3.9% y/y, compared to the previous numbers of +0.3% m/m and +3.8% y/y.
U.S. Factory Orders data will be released today. Economists foresee this figure coming in at +4.4% m/m in March, compared to the previous number of +0.6% m/m.
The U.S. Unemployment Rate will be reported today as well. Economists forecast that this figure will remain steady at 4.2% in April.
In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 4.202%, down -0.69%.
The Euro Stoxx 50 Index is up +1.35% this morning as signs of a possible easing in U.S.-China trade tensions boosted sentiment, while investors digest a wave of corporate earnings reports and key economic data from the region. Mining and bank stocks led the gains on Friday. The benchmark index is on track to end the week higher. Preliminary data from Eurostat released on Friday showed that the Eurozone's headline inflation remained slightly above the European Central Bank's target in April, while underlying inflation picked up more than expected, likely causing concern among some ECB policymakers. Separately, a survey showed that Eurozone manufacturing output expanded at the quickest rate in just over three years in April, despite overall factory activity staying in contraction territory, as the region's three largest economies showed signs of improvement. In corporate news, Shell Plc (SHEL.LN) rose over +3% after the oil major posted better-than-expected Q1 profit and announced a $3.5 billion share buyback. Also, Danske Bank A/S (DANSK.C.DX) gained more than +2% after Denmark's biggest lender reported stronger-than-expected Q1 profit and reaffirmed its full-year profit guidance. In addition, Airbus SE (AIR.FP) climbed over +4% after the planemaker posted upbeat quarterly results and reaffirmed its full-year guidance.
Eurozone's Manufacturing PMI, Eurozone's CPI (preliminary), Eurozone's Core CPI (preliminary), and Eurozone's Unemployment Rate were released today.
Eurozone April Manufacturing PMI stood at 49.0, stronger than expectations of 48.7.
Eurozone April CPI came in at +2.2% y/y, stronger than expectations of +2.1% y/y.
Eurozone April Core CPI arrived at +2.7% y/y, stronger than expectations of +2.5% y/y.
Eurozone March Unemployment Rate was 6.2%, weaker than expectations of 6.1%.
Japan's Nikkei 225 Stock Index (NIK) closed up +1.04%, while mainland China's financial markets were closed for a holiday.
Japan's Nikkei 225 Stock Index closed higher today on positive comments from the nation's chief trade negotiator. A weaker yen also boosted appetite for Japanese stocks. In addition, optimism surrounding potential trade talks between China and the U.S. bolstered sentiment across the region. Pharmaceutical and chemical stocks led the gains on Friday. The benchmark index posted its seventh consecutive session of gains, marking its longest winning streak since August 2023. It also notched a third consecutive weekly gain. Japan's top trade representative, Ryosei Akazawa, stated on Thursday that he aims to reach a trade agreement with the U.S. in June, with the high-stakes bilateral talks anticipated to speed up in mid-May. His remarks followed the conclusion of the latest round of talks in Washington. Meanwhile, Japan's Finance Minister Katsunobu Kato said the country's U.S. Treasury holdings could be a card in its trade talks with Washington. 'Whether or not we use that card is a different decision,' he added. On the economic front, government data released on Friday showed that Japan's unemployment rate unexpectedly edged up in March. In corporate news, Yamato Holdings climbed over +5% after the package delivery services provider issued strong full-year operating profit guidance. The Nikkei Volatility Index, which takes into account the implied volatility of Nikkei 225 options, closed up +1.87% to 26.74.
The Japanese March Unemployment Rate was 2.5%, weaker than expectations of 2.4%.
China's Shanghai Composite Index was closed today for the Labor Day holiday. Mainland China's financial markets will reopen on Tuesday, May 6th.
Pre-Market U.S. Stock Movers
Apple (AAPL) fell over -2% in pre-market trading after the iPhone maker reported weaker-than-expected FQ2 sales in China.
Amazon.com (AMZN) slid more than -2% in pre-market trading after the world's largest online retailer provided a below-consensus Q2 operating income forecast.
Atlassian (TEAM) tumbled over -16% in pre-market trading after the collaboration and productivity software firm issued weak FQ4 revenue guidance.
Reddit (RDDT) climbed more than +8% in pre-market trading after the company posted upbeat Q1 results and gave strong Q2 revenue guidance.
Block (XYZ) plummeted over -21% in pre-market trading after the digital-payments company reported weaker-than-expected Q1 results and cut its full-year gross profit guidance.
You can see more pre-market stock movers here
Today's U.S. Earnings Spotlight: Friday - May 2nd
Exxon Mobil (XOM), Chevron (CVX), Eaton (ETN), Cigna (CI), Apollo Global Management (APO), Natwest Group (NWG), Imperial Oil (IMO), DuPont De Nemours (DD), Cboe Global (CBOE), T Rowe (TROW), Brookfield Renewable (BEP), Westlake Chemical (WLK), Magna Intl (MGA), Franklin Resources (BEN), nVent Electric (NVT), The AES (AES), Fluor (FLR), United States Cellular (USM), Brookfield Business (BBU), Madison Square Garden Sports (MSGS), Piper Sandler (PIPR), Telephone&Data Systems (TDS), Cinemark (CNK), Brightspring Health Services (BTSG), Atmus Filtration Tech (ATMU), The Wendy's Co (WEN), Amneal Pharma (AMRX), Terex (TEX), Arbor (ABR), Criteo Sa (CRTO), Patria Investments (PAX), Perella Weinberg Partners (PWP), WisdomTree (WT), Xenia Hotels & Resorts (XHR), Interface (TILE).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Can OpenAI really go the way of Apple and capture lightning in a bottle?
Gus Carlson is a U.S.-based columnist for The Globe and Mail. After OpenAI's series of embarrassing stumbles – including disruptive outages, pesky glitches in its ChatGTP platform, and the bizarre ousting and rehiring of its chief executive officer in a matter of days – the popular artificial-intelligence platform finally got one right. So right, in fact, that the company has manoeuvred itself into a position to put some blue water between itself and deep-pocketed rivals in the development of AI devices, the way Apple did with rivals in the computer and mobile phone world. The Apple comparison is not coincidental. Late last month, OpenAI said it planned to acquire an AI device company called io in an all-equity deal valued at about US$6.4-billion. Embedded in the purchase is a secret weapon that goes well beyond the technology: the design legend and io co-founder Jony Ive. OpenAI recruits legendary iPhone designer Jony Ive to work on AI hardware in $6.5B deal Mr. Ive is not just another smart techie. He is the design genius responsible for creating Apple's most iconic products, including the iPod, iPhone, iPad and MacBook Air. He also helped design Apple's ultra-modern California headquarters. It was Mr. Ive's eye for combining elegant simplicity and functionality that set Apple's products apart from all others, first in the world of PCs and then in handheld devices. Even Apple's packaging reflects Mr. Ives's commitment to reinforcing the brand's sleek beauty in every way it touches customers. So influential was Mr. Ive that Apple co-founder Steve Jobs said he considered him to be his 'spiritual partner' who saw things the same way he did. Mr. Ive was among Mr. Jobs's first hires when he returned to Apple in 1997 after being fired from the company more than a decade earlier. Mr. Ive had a direct and unfettered reporting relationship with Mr. Jobs. Few would question Mr. Ive's enormous influence on the devices we all use every day. In a post about the io acquisition on X, OpenAI CEO Sam Altman wrote that Mr. Ive is 'the greatest designer in the world.' OpenAI needs a win. The acquisition of Mr. Ive and io is a crucial strategic play for OpenAI to stay ahead in the generative AI race, where competitors including Google, Anthropic and Elon Musk's xAI are making significant investments and quickly pushing new products to market. The showdown in AI devices is seen as the next big inflection point for the sector that may drive consolidation and some flame-outs – fates OpenAI seems determined to avoid. The purchase of io – OpenAI already owns about 23 per cent of the company – is the latest in a recent shopping spree that has seen OpenAI shore up its hardware assets. Just a few weeks ago, it agreed to buy AI-assisted coding tool Windsurf for US$3-billion. OpenAI also acquired analytics database company Rockset last year. OpenAI has also hired the former head of Meta's Orion augmented reality glasses initiative to lead its robotics and consumer hardware efforts. OpenAI CFO says new structure opens door for potential IPO Despite the asset and talent accumulation, OpenAI has some hurdles to clear with its current offerings, as well some reputation issues that continue to dog its credibility. The company has been plagued by high error rates in its application programming interface (API) and performance problems in ChatGTP. Users have reported a wide range of gremlins, including slow response times, trouble mining information from source documents, contextual problems and generic responses to queries. But perhaps OpenAI's biggest black eye came in November, 2023, when its board ousted Mr. Altman as CEO because of concerns about his leadership capabilities and lack of transparency in his communications with directors. Then, just a few days later, after employees protested the firing and threatened a mass walk-out, Mr. Altman was reinstated as CEO. An independent investigation concluded that the board's initial concerns about Mr. Altman did not rise to the threshold for termination. But the damage was done. The chaos in the governance structure dealt a blow to OpenAI's reputation at a time in its young life when it was breaking new ground and trying to establish credibility in the fast-emerging AI space. If history is any guide, Mr. Ive's eye for the kind of elegant, simple and unique device designs that separated Apple from the pack will give OpenAI an advantage over its bigger rivals. The big questions are: Can he capture lightning in a bottle again, the way he did at Apple, and will he be given the latitude to pursue the unique creative path that has made him a tech legend? Based on OpenAI's past governance bungling, Mr. Altman's biggest job is to keep the board out of Mr. Ive's hair and let him work his magic. If they can manage that, oh, the places they'll go.
Globe and Mail
4 hours ago
- Globe and Mail
Should You Invest in Quantum Computing Stocks During the TACO Trade?
It's been a hard year for investors so far. As of market close on June 5, the S&P 500 and Nasdaq Composite indexes each have breakeven returns on the year. While this makes it incredibly difficult to make money in the stock market, there have been some pockets during which investors made out well if they chose to engage with higher-than-usual volatility. By now, you may have come across a new acronym floating around financial circles called the "TACO" trade. Below, I'll detail what this means and why it's important. From there, I'll dig into one of the new, hot areas fueling the artificial intelligence (AI) narrative: quantum computing. Could quantum computing stocks be a good way to play the TACO trade? Read on to find out. What is the TACO trade? Even though the S&P 500 and Nasdaq are both flat on the year, the image below illustrates that there have been some pronounced dips and sharp rises across both indexes throughout 2025. The catch is that these volatile movements have been incredibly fleeting. ^SPX data by YCharts The term "TACO trade" is a cheeky acronym that stands for "Trump always chickens out." Basically, whenever the President voiced some tough rhetoric on his new tariff policies, the markets plummeted. However, when he subsequently eases some of the pressure on the tariff talking points, the markets roar again. In summary, the TACO trade is simply a new version of buying the dip when stock prices become abnormally depressed. Are quantum computing stocks a good buy right now? Two of the most popular quantum computing stocks in the market right now are IonQ (NYSE: IONQ) and Rigetti Computing (NASDAQ: RGTI). During 2024, shares of IonQ soared by 237% while Rigetti stock climbed by a jaw-dropping 1,450% -- both of which completely dominated the broader market. This year has been a different story, though. As of closing bell on June 5, shares of IonQ and Rigetti Computing have plummeted by 12% and 28%, respectively. Given these declines, is now a good opportunity to buy quantum computing stocks? To answer that question, smart investors understand that valuation needs to be a consideration. Per the chart below, Rigetti Computing and IonQ boast price-to-sales (P/S) ratios that seem incongruent with the company's underlying fundamentals. RGTI PS Ratio data by YCharts Looked at another way, IonQ and Rigetti Computing have generated a combined revenue of roughly $50 million over the last 12 months -- all while posting a net loss of $460 million between the two businesses. Given the nominal sales figures and hemorrhaging losses, it's hard to justify the valuation multiples pictured above. While Rigetti and IonQ have each been on a monster run from a share price perspective, both of these companies appear to be riding high on a bullish quantum computing narrative. In other words, their trading levels are not rooted in the actual performance of the business but rather in a broader macro viewpoint that quantum computing could be a good opportunity in the long run. Keep the big picture in focus The big takeaway here is that even though shares of IonQ and Rigetti are down on the year, their respective valuations make it clear that neither of these companies is a good "buy the dip" candidate. Rather, even with their underperformance throughout the year, each stock remains overvalued. For these reasons, I would not chase any sell-offs in these quantum computing stocks as the TACO trade continues to evolve. My suspicion is that both IonQ and Rigetti will experience some continued valuation compression, and their share prices could very well keep spiraling downward. Should you invest $1,000 in IonQ right now? Before you buy stock in IonQ, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and IonQ wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
Globe and Mail
6 hours ago
- Globe and Mail
Better Buy: Palantir Stock vs. UnitedHealth Group Stock
Two stocks that have been at the center of financial news stories throughout the year are data mining specialist Palantir Technologies (NASDAQ: PLTR) and health insurance giant UnitedHealth Group (NYSE: UNH). The reasons these two companies are fetching so much attention, however, couldn't be more opposite. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Palantir has emerged as a darling of the artificial intelligence (AI) revolution. As of this writing (June 5), shares of the stock have gained nearly 60% on the year -- making it one of the top performers in the S&P 500 and Nasdaq-100 indexes. By contrast, UnitedHealth Group stock is the worst-performing name in the Dow Jones Industrial Average -- with shares plummeting by more than 40%. Is now the time to hop on the Palantir train, or should investors take an inventory check on UnitedHealth and choose to buy the dip? Palantir is on a run for the ages It's been just over two years since Palantir released its Artificial Intelligence Platform (AIP), a software suite that's proven to be a transformative game changer in the company's pursuit of competing with the largest players in the tech landscape. PLTR Revenue (Quarterly) data by YCharts Since releasing AIP, Palantir has unlocked a new wave of revenue acceleration -- thanks in large part to the company's impressive penetration of the private sector. For most of its history, Palantir relied heavily on government contracts from the Department of Defense (DOD). While deals with the U.S. Military and its allies are still an important cornerstone of Palantir's business, AIP has helped the company break ground in a host of other use cases -- financial fraud, supply chain and logistics, aviation, and much more. What might be most impressive about Palantir's transformation over the last two years is how rapidly the company transitioned from a cash-burning operation to one that generates consistent profitability. Not only is Palantir acquiring new business, but it's also monetizing these customers in a profitable way. That's a lucrative combination, indeed. The one idea that's paramount for smart investors to understand is that while Palantir's business is soaring, so is the company's share price. As of this writing, Palantir trades at a price-to-sales (P/S) ratio of 97. Not only is that magnitudes higher than any of its peers in the software realm, but it is historically high compared to what investors witnessed during the dot-com bubble in the late 1990s. I don't think I'm the only one who has noticed the pronounced valuation expansion in Palantir, either. Consider that Cathie Wood's Ark Invest portfolio has been trimming Palantir stock as of late, and billionaire money manager Stanley Druckenmiller completely dumped his firm's stake in the AI stock during the first quarter. UnitedHealth Group can't seem to get out of its own way UnitedHealth Group's coverage couldn't be any more different than Palantir's. While investors continue to cheer on Palantir's dominance, it seems that only negativity surrounds UnitedHealth at the moment. At the core of the health insurer's problems are some operational hiccups. Mismanagement in forecasting utilization rates in the company's Medicare Advantage business, as well as some unforeseen challenges in the pharmacy benefits management (PBM) segment, caused management to reduce financial guidance for 2025. If this weren't enough to get investors worked up, UnitedHealth also replaced its CEO as the company seeks to right the ship and turn things around by next year. UnitedHealth's downward revision and executive changes were met with a stock sell-off for the ages. Don't believe me? As of this writing, shares of UnitedHealth trade at $296 -- hovering near a five-year low. Which stock is the better buy? Despite its near-term headwinds, UnitedHealth stock looks awfully tempting at a forward price-to-earnings (P/E) multiple of just 13. When you consider that insiders have been buying the stock in the aftermath of this epic sell-off, I'm cautiously optimistic that all of the bad news surrounding UnitedHealth is priced in. UNH PE Ratio (Forward) data by YCharts On the other side of the equation, I think it's becoming increasingly difficult to argue that max upside isn't already priced into Palantir. Sure, I'm bullish on the company's future, but buying the stock near an all-time high doesn't seem like a prudent idea right now. Overall, I'd choose to buy the dip in UnitedHealth as opposed to chasing the momentum fueling Palantir stock at the moment. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Adam Spatacco has positions in Palantir Technologies. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.
